🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Combined Effects of LIRT-BFR Therapy in Post- Stroke Patients

RecruitingNAAges 50 Years - 70 YearsAllRiphah International University
NCT07646418 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Stroke is a focal neurological deficit of sudden onset, with symptoms lasting more than 24 hours leading to consequences like impacting physical abilities, cognitive functions and emotional well-being, speech and language difficulties. Among various rehabilitation program, Blood flow restriction (BFR) therapy with low intensity resistance training has shown its promising results. Blood flow restriction training, also called Kaatsu, originated in Japan. So this study aims to determine the combined effects of Low Intensity Resistance Training with Blood Flow Restriction Therapy on Upper Limb Strength, Forward Reach and Sensorimotor function in Post-Stroke Patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * • 50 to 70 year of age (5) * Both males and females (5) * Generalized stroke population (both ischemic and hemorrhagic stroke) (9). * Post stroke patient after 1 month (5) * Barthel index scores ≥ 20 (10) * Spasticity level according to Modified Ashworth scale should be 1/+1 grade in the affected upper limb(7) * Muscle strength at grade 3 according to MMT of affected upper limb (7) Exclusion Criteria: * • People with a history of mental/cognitive illness (9) * History of transient ischemic attack (TIA) or recurrent stroke (8) * Diabetes with peripheral neuropathy (5) * Having resting blood pressure above 160/100 mmHg even after taking medications * Cardiovascular comorbidity (heart failure, unstable angina, aortic stenosis)
💊

What it tests

  • Low intensity resistance training with Blood flow restriction therapy
  • Conventional Physical Therapy Protocol
📍

Where

1 site
Amin Welfare & Teaching Hospital
Sialkot, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy